Skip to content

Treatment of Sciatica by Cupping therapy

An Open label, Randomized, Comparative Clinical Study to Evaluate the Efficacy of Hijamah bil shart (wet cupping) at Two Different Sites in the Management of Sciatica

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/08/071801
Enrollment
60
Registered
2024-08-01
Start date
Unknown
Completion date
Unknown
Last updated
2026-01-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M00-M99- Diseases of the musculoskeletal system and connective tissue

Interventions

Intervention1: Hijamah bil shart at LS Spine: Hijamah bil shart (wet cupping) will be done with 2 cups placed paravertebral area at L4-L5 or L5-S1 Control Intervention1: Hijamah bil shart at lower mos

Sponsors

Jamia Hamdard univrsity
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Age- 18 to 65 years. All genders. Already diagnosed patients of sciatica(chronic cases) having constant pain since 3 months or more presenting with all or some of the following signs and symptoms. Unilateral leg pain greater than low back pain radiating towards leg/ foot/toes. Numbness and/ tingling sensation in the same distribution. Positive straight-leg-raising test. Pain intensity score of 30-60 mm on a 100-mm visual analog scale (VAS). Willingness to accept wet cupping intervention

Exclusion criteria

Exclusion criteria: Pregnant and lactating women. Patients of previous back surgery or lumbar spine surgery. Patients of spinal tumors, gross or fixed developmental deformity, cauda equine or vertebral fracture. Pelvic or Back trauma. Rheumatoid Arthritis. Ankylosing spondylosis. Patients of bleeding disorders. Patients of anaemia (Hb less than 10 gm) Patients with Chronic liver, kidney or heart disease Motor weakness or Muscle wasting Patients suffering from Psychiatric disorders HCV and HBsAg positive patients History of stroke, severe hypertension and uncontrolled diabetes mellitus Unwilling to participate in the study.

Design outcomes

Primary

MeasureTime frame
Reduction in Pain intensity and other symptoms of Sciatica. Improvement in Range of motion of hip jointTimepoint: Day 1 and Day 42

Secondary

MeasureTime frame
Reduction in time to climb stairs. An increase in distance covered in 6 minutes walk on plain surfaceTimepoint: Day 1 and Day 42

Countries

India

Contacts

Public ContactDr Md Wasi Akhtar

Jamia Hamdard

drmdwasiakhtar@jamiahamdard.ac.in9027570265

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026